Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04085406 · ClinicalTrials.gov registry record · NA

DBS of the SCC for the Treatment of Medically Refractory CLBP

A NA study of Chronic Low Back Pain, sponsored by University of California, Los Angeles.

Recruiting
Registry status
NA
Development phase
16
Enrollment target
2
Study locations

NCT04085406 is a NA study of Chronic Low Back Pain that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 16 participants, below the 592-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04085406, a NA study of Chronic Low Back Pain, is actively recruiting participants, sponsored by University of California, Los Angeles.

RECRUITING
Registry status
NA
Development phase
16 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to evaluate the feasibility and preliminary efficacy of deep brain stimulation of the subgenual cingulate cortex for the treatment of chronic medically-refractory low back pain using a randomized double-blind crossover design.

Conditions Studied

Interventions

  • DEVICE Deep Brain Stimulation of the Subgenus Cingulate Cortex

Study Locations (2)

California

  • University of California Los Angeles - Los Angeles

Texas

  • University of Texas Southwestern Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2021-05-01
Est. Completion 2027-06-30
Phase NA

What the Registry Record Tells You About NCT04085406

The ClinicalTrials.gov registry entry for NCT04085406 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 592-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (97% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Low Back Pain appearing as the primary indexed condition, and to 1 intervention - of which Deep Brain Stimulation of the Subgenus Cingulate Cortex is the first listed.

NCT04085406 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Texas.

Frequently Asked Questions

What is clinical trial NCT04085406 about?

NCT04085406 is a clinical study titled "DBS of the SCC for the Treatment of Medically Refractory CLBP". The purpose of this study is to evaluate the feasibility and preliminary efficacy of deep brain stimulation of the subgenual cingulate cortex for the treatment of chronic medically-refractory low back pain using a randomized double-blind crossover design.

What is the current status of trial NCT04085406?

This trial is currently recruiting. It is a NA study. The enrollment target is 16 participants. The study started on 2021-05-01. Estimated completion is 2027-06-30.

What conditions does trial NCT04085406 study?

This clinical trial studies the following conditions: Chronic Low Back Pain.

What interventions are being tested in trial NCT04085406?

The interventions under investigation include: Deep Brain Stimulation of the Subgenus Cingulate Cortex (DEVICE).

Who is sponsoring clinical trial NCT04085406?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04085406 being conducted?

This trial has 2 study locations across California, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Low Back Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.